This indefinite-delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Genentech USA, Inc. as the prime contractor. The contract, valued at $27,898,886.92, has an ultimate completion date of May 21, 2031 and enables DLA Troop Support Medical to issue delivery orders for a variety of pharmaceutical and medical supplies.
Under this IDC, Genentech has fulfilled numerous delivery orders to provide items such as Tamiflu, Activase, TNKase, clonazepam, and diazepam tablets. These orders range in value from several hundred dollars to over $500,000 and support DLA Troop Support Medical's mission to procure critical pharmaceuticals and medical supplies for the U.S. military. The contract does not utilize any set-aside designations, and all performance occurs at Genentech's facility in South San Francisco, California. This IDC provides DLA Troop Support Medical with a flexible, established contract vehicle to efficiently meet the Department of Defense's diverse pharmaceutical and medical product requirements.
Generated 8/14/24, 9:08 AM